IP Library Granted Patent US 8,108,031
Granted Patent B2
US 8,108,031 · App. 11/895,702 · Granted Jan 31, 2012

Methods for in-vivo flow cytometry

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,108,031
App. No.
11/895,702
Granted
Jan 31, 2012
Kind
B2
Abstract

The present invention provides methods and systems for performing in-vivo flow cytometry to obtain desired information regarding one or more cell types of interest flowing through a subject's circulatory system. In one embodiment of the invention, a portion of the subject's circulating blood is illuminated with radiation having multiple wavelength components, and the backscattered radiation generated in response to the excitation radiation is detected at a plurality of scattering angles and analyzed to derive the desired information.

Claims (23)

1. A method of performing flow cytometry, comprising

illuminating in vivo a portion of a subject's circulating blood with radiation having at least two selected wavelength components,

for each wavelength component, measuring intensity of backscattered radiation from the illuminated blood at two or more angular locations, and

analyzing said intensity measurements to derive information regarding one or more cell types of interest present in said circulating blood.

2. The method of claim 1 , wherein one of said wavelength components is selected to lie in a spectral region associated with low hemoglobin absorption and another of said wavelength components is selected to lie in a spectral region associated with high hemoglobin absorption.

3. The method of claim 1 , wherein said step of illuminating comprises simultaneously illuminating said blood portion with radiation having said at least two wavelength components.

4. The method of claim 1 , wherein said step of illuminating comprises illuminating said blood portion with radiation having one of said wavelength components and in a subsequent time interval illuminating said blood portion with radiation having another one of said wavelength components.

5. The method of claim 1 , wherein at least one of said angular locations is selected to lie within a circular strip in a plane of backscattered radiation, said circular strip being defined by first and second azimuthal angles relative to a central axis of said backscattered radiation and first and second polar angles.

6. A method for detection and quantification of a cell type of interest present in a subject's circulatory system, comprising

illuminating in vivo a subject's circulating blood with radiation having multiple wavelength components,

detecting backscattered radiation at two or more angular regions having different scattering angles relative to a central axis of said backscattered radiation, and

analyzing said detected radiation as a function of wavelength and scattering angle to derive selected information regarding said cell type.

7. The method of claim 6 , wherein said information comprises a relative count of said cell type.

8. The method of claim 7 , further comprising selecting another one of said angular regions to include locations forming backscattered (polar) angles in a range of about 5 to about 12 degrees.

9. The method of claim 6 , further comprising selecting said multiple wavelengths to be in a range of about 450 nm to about 1000 nm.

10. The method of claim 6 , further comprising selecting at least two of said wavelength components to lie in a two regions of hemoglobin absorption spectrum.

11. The method of claim 6 , further selecting at least one of said angular regions to include locations forming backscattered (polar) angles in a range of about zero to about 5 degrees relative to said central axis.

12. The method of claim 6 , further comprising selecting at least one of said angular regions to include an annular region in a plane perpendicular to said central axis confined between defined by first and second polar angles relative to a central axis of backscattered radiation and first and second azimuthal angles.

13. The method of claim 12 , further comprising selecting said first and second azimuthal angles to be, respectively, about zero and about 90 degrees.

14. The method of claim 12 , further comprising selecting said first and second azimuthal angles to be, respectively, about zero and about 180 degrees.

15. The method of claim 12 , further comprising selecting said first and second polar angles to be, respectively, about zero and about 360 degrees.

16. The method of claim 6 , wherein the step of detecting backscattered radiation in at least one of said angular regions comprises integrating backscattered radiation intensity at a plurality of locations in said angular region.

17. The method of claim 6 , wherein the step of analyzing said detected radiation comprises differentiating said cell type from other cell types present in the subject's circulating blood based on measured intensities of the detected backscattered radiation at least two wavelengths and at least two different scattering angles.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 20, 2010
From: THE GENERAL HOSPITAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023813/0869 →
Continuity (2)
Division 11016545 · Dec 17, 2004
Related Publication 20070299327A1 · Dec 27, 2007